NIOX Group PLC

Research NIOX Group PLC (NIOX) on Bullrun: market cap GBX 23.40B, P/E 27.8, dividend yield 2.7%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerNIOX
• ExchangeLSE
• CountryUnited Kingdom
• SectorHealthcare
• IndustryMedical Devices
• CurrencyGBX
• Market capGBX 23.40B
• P/E27.8
• Dividend yield2.7%
• Financial periodFY2025
• RevenueGBP 48.70M
• Revenue growth16.5%
• Net incomeGBP 7.00M
• Free cash flowGBP 13.90M
• Gross margin69.2%

Valuation Snapshot

latest market cap is GBX 23.40B; P/E is 27.8; dividend yield is 2.7%.

About NIOX Group PLC

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, sensors, individual disposable mouthpieces, and breathing handles for the measurement of fractional exhaled nitric oxide (FeNO) level in patients.

Frequently asked questions

What is NIOX Group PLC's market cap?

NIOX Group PLC's market capitalization is GBX 23.40B.

What is NIOX Group PLC's P/E ratio?

NIOX Group PLC's price-to-earnings (P/E) ratio is 27.8.

Does NIOX Group PLC pay a dividend?

NIOX Group PLC has a dividend yield of 2.7%.

What does NIOX Group PLC do?

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide.